William P.D. Hendricks

2.6k total citations
43 papers, 926 citations indexed

About

William P.D. Hendricks is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William P.D. Hendricks has authored 43 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Pathology and Forensic Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William P.D. Hendricks's work include Chromatin Remodeling and Cancer (15 papers), Cancer Mechanisms and Therapy (14 papers) and Veterinary Oncology Research (9 papers). William P.D. Hendricks is often cited by papers focused on Chromatin Remodeling and Cancer (15 papers), Cancer Mechanisms and Therapy (14 papers) and Veterinary Oncology Research (9 papers). William P.D. Hendricks collaborates with scholars based in United States, Canada and France. William P.D. Hendricks's co-authors include Jeffrey M. Trent, Jessica D. Lang, David G. Huntsman, Bernard E. Weissman, Anthony N. Karnezis, Mark C. Preul, Adrienne C. Scheck, Wolfgang Pfisterer, Krystal A. Orlando and Yemin Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

William P.D. Hendricks

40 papers receiving 915 citations

Peers

Countries citing papers authored by William P.D. Hendricks

Since Specialization

Citations

This map shows the geographic impact of William P.D. Hendricks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P.D. Hendricks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P.D. Hendricks more than expected).

Fields of papers citing papers by William P.D. Hendricks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P.D. Hendricks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P.D. Hendricks. The network helps show where William P.D. Hendricks may publish in the future.

Co-authorship network of co-authors of William P.D. Hendricks

This figure shows the co-authorship network connecting the top 25 collaborators of William P.D. Hendricks. A scholar is included among the top collaborators of William P.D. Hendricks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William P.D. Hendricks. William P.D. Hendricks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type 2025 ·iScience ·Jessica D. Lang, (unknown), (unknown), (unknown), (unknown), Anthony N. Karnezis, F. Kommoss, Friedrich Kommoss, (unknown), Salvatore Facista, William P.D. Hendricks, Krystal A. Orlando, Patrick Pirrotte, (unknown), Victoria Zismann, Yemin Wang, David G. Huntsman, Bernard E. Weissman, Jeffrey M. Trent	0
2	Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival 2025 ·Scientific Reports ·A. Heiden, (unknown), (unknown), Heather L. Gardner, William P.D. Hendricks, Victoria Zismann, Shukmei Wong, Natalia Briones, (unknown), Karin Forsberg‐Nilsson, Cheryl A. London, Kerstin Lindblad‐Toh, Maja L. Arendt	0
3	Precision Medicine in Veterinary Science 2024 ·Veterinary Clinics of North America Small Animal Practice ·(unknown), William P.D. Hendricks, Michelle E. White, (unknown), (unknown), Gerald Post	6
4	Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC 2023 ·Veterinary and Comparative Oncology ·Sharadha Sakthikumar, Salvatore Facista, (unknown), Sara A. Byron, (unknown), (unknown), Zhanyang Zhu, (unknown), (unknown), (unknown), William P.D. Hendricks, (unknown)	3
5	Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel 2023 ·Biomarker Research ·Jessica D. Lang, (unknown), Maren K. Levin, (unknown), (unknown), (unknown), Natalia Briones, Claudius Mueller, (unknown), Sarah Moore, Victoria Zismann, William P.D. Hendricks, Virginia Espina, Joyce O’Shaughnessy	3
6	Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions 2022 ·Scientific Reports ·(unknown), (unknown), Bradon R. McDonald, (unknown), Tania Contente‐Cuomo, Shukmei Wong, William P.D. Hendricks, Jeffrey M. Trent, Chand Khanna, Muhammed Murtaza	5
7	Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients 2022 ·PLoS ONE ·Shukmei Wong, E. J. Ehrhart, (unknown), Victoria Zismann, (unknown), Rebecca F. Halperin, Natalia Briones, Keith Richter, Karthigayini Sivaprakasam, Nieves Perdigones, Tania Contente‐Cuomo, Salvatore Facista, Jeffrey M. Trent, Muhammed Murtaza, Chand Khanna, William P.D. Hendricks	14
8	Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines 2020 ·Clinical Cancer Research ·Marc Tischkowitz, Sidong Huang, Susana Banerjee, Jennifer Hague, William P.D. Hendricks, David G. Huntsman, Jessica D. Lang, Krystal A. Orlando, Amit M. Oza, Patricia Pautier, Isabelle Ray‐Coquard, Jeffrey M. Trent, Michael Witcher, Leora Witkowski, W. Glenn McCluggage, Douglas A. Levine, William D. Foulkes, Bernard E. Weissman	84
9	The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer 2020 ·PLoS ONE ·Raffaella Soldi, Tithi Ghosh, (unknown), (unknown), Kevin Drenner, (unknown), Mohan R. Kaadige, (unknown), (unknown), (unknown), Jessica D. Lang, Hariprasad Vankayalapati, Bernard E. Weissman, Jeffrey M. Trent, William P.D. Hendricks, Sunil Sharma	60
10	Polymerase chain reaction for antigen receptor rearrangement: Benchmarking performance of a lymphoid clonality assay in diverse canine sample types 2019 ·Journal of Veterinary Internal Medicine ·E. J. Ehrhart, Shukmei Wong, Keith Richter, Victoria Zismann, (unknown), William P.D. Hendricks, Chand Khanna	10
11	Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma 2019 ·Clinical Cancer Research ·Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann, Nieves Perdigones, Tania Contente‐Cuomo, (unknown), Salvatore Facista, Shukmei Wong, Kevin Drenner, Winnie S. Liang, Joseph M. Amann, (unknown), Michael J. Koenig, Krista La Perle, Timothy G. Whitsett, Muhammed Murtaza, Jeffrey M. Trent, David P. Carbone, William P.D. Hendricks	28
12	Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type 2018 ·Molecular Cancer Therapeutics ·Yemin Wang, (unknown), Shane Colborne, (unknown), (unknown), Nancy Dos Santos, Krystal A. Orlando, Jessica D. Lang, William P.D. Hendricks, Marcel B. Bally, Anthony N. Karnezis, Ralf Hass, T. Michael Underhill, Gregg B. Morin, Jeffrey M. Trent, Bernard E. Weissman, David G. Huntsman	52
13	Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients 2018 ·Frontiers in Genetics ·(unknown), Darren Finlay, Hongwei Yin, William P.D. Hendricks, Chris Sereduk, Jeffrey Kiefer, Aleksandar Sekulić, Patricia LoRusso, Kristiina Vuori, Jeffrey M. Trent, Nicholas J. Schork	3
14	The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type 2016 ·Gynecologic Oncology ·Leora Witkowski, Catherine Goudie, Pilar Ramos, Talia Boshari, Jean‐Sébastien Brunet, Anthony N. Karnezis, Michel Longy, James A. Knost, Emmanouil Saloustros, W. Glenn McCluggage, Colin J.R. Stewart, William P.D. Hendricks, Heather E. Cunliffe, David G. Huntsman, Patricia Pautier, Douglas A. Levine, Jeffrey M. Trent, Andrew Berchuck, Martin Hasselblatt, William D. Foulkes	86
15	Abstract 3422: The influence of genetic and clinical factors on the outcome following a diagnosis of small cell carcinoma of the ovary, hypercalcemic type 2016 ·Cancer Research ·Leora Witkowski, Catherine Goudie, Pilar Ramos, Anthony N. Karnezis, Talia Boshari, Patricia Pautier, Michel Longy, James A. Knost, Emmanouil Saloustros, W. Glenn McCluggage, Martin Hasselblatt, William P.D. Hendricks, David G. Huntsman, Douglas A. Levine, Jeffrey M. Trent, William D. Foulkes	1
16	Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials 2014 ·PLoS ONE ·Melissa Paoloni, Craig P. Webb, Christina Mazcko, David Cherba, William P.D. Hendricks, Susan E. Lana, E. J. Ehrhart, (unknown), (unknown), (unknown), David M. Vail, Michael S. Henson, Michael O. Childress, Barbara E. Kitchell, Christopher Kingsley, Seungchan Kim, Mark W. Neff, Barbara J. Davis, Chand Khanna, Jeffrey M. Trent	26
17	Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) 2014 ·PubMed ·Pilar Ramos, Anthony N. Karnezis, William P.D. Hendricks, Yemin Wang, Waibhav Tembe, Victoria Zismann, Christophe Legendre, Winnie S. Liang, Megan Russell, David W. Craig, John Farley, Bradley J. Monk, Stephen P. Anthony, Aleksandar Sekulić, Heather E. Cunliffe, David G. Huntsman, Jeffrey M. Trent	40
18	FLUORESCENT IN SITU HYBRIDIZATION AND EX VIVO 1H MAGNETIC RESONANCE SPECTROSCOPIC EXAMINATIONS OF MENINGIOMA TUMOR TISSUE 2007 ·Neurosurgery ·Wolfgang Pfisterer, William P.D. Hendricks, Adrienne C. Scheck, Ronald A. Nieman, Thomas Birkner, Wolfgang Krampla, Mark C. Preul	27
19	Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue 2007 ·Journal of Neuro-Oncology ·Wolfgang Pfisterer, Stephen W. Coons, Fahmy Aboul‐Enein, William P.D. Hendricks, Adrienne C. Scheck, Mark C. Preul	28
20	Diagnostic and prognostic significance of genetic regional heterogeneityin meningiomas 2004 ·Neuro-Oncology ·Wolfgang Pfisterer, Nicole Hank, Mark C. Preul, William P.D. Hendricks, (unknown), Stephen W. Coons, Adrienne C. Scheck	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact